Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1108652

	registered interest
	date	01/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cancer: Research
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the effect of leaving the European Research Area on access to EU framework programme funding for UK-based cancer research projects.
	tabling member constituency	Houghton and Sunderland South
	tabling member printed	Bridget Phillipson
	uin	239229
	answer	answer is ministerial correction date of answer 04/04/2019 answer text <p>European Union Framework Programme funding for United Kingdom-based projects, including those on cancer research, will not necessarily be linked to the UK’s involvement in the European Research Area.</p><p> </p><p>If we leave with the Withdrawal Agreement, UK participants will still be eligible for funding from Horizon 2020, including for cancer research projects. As a responsible Government, we are continuing to prepare for a ‘no deal’ scenario. In a ‘no deal’ scenario, the Government has committed to fund all successful UK bids to Horizon 2020 submitted before the end of 2020 and for the lifetime of projects. This guarantee will enable UK researchers and businesses to continue to access funding required to participate in Horizon 2020 and will support ongoing world-leading collaboration, including in cancer research.</p><p> </p><p>Looking beyond Horizon 2020, in any scenario we want to continue to back the UK research and innovation community by supporting the provision of opportunities for world-class collaborative research. We are continuing to seek a relationship with the European Union on science and innovation including the option of future association to excellence-based EU research and innovation funding programmes.</p><p> </p><p>National Institute for Health Research cancer research expenditure has risen from £101 million in 2010/11 to £136 million in 2017/18. This constitutes the largest investment in a disease area. A large proportion of this funding comprises support for the delivery of Cancer Research UK-funded research in the National Health Service.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 04/04/2019 11:13:19 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	4046 label Biography information for Bridget Phillipson

1108671

	registered interest
	date	01/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Barts Health NHS Trust: Breast Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of trends in the number of symptomatic breast appointments in Barts Health NHS Trust in each of the last five years.
	tabling member constituency	East Ham
	tabling member printed	Stephen Timms
	uin	239164
	answer	answer is ministerial correction date of answer 04/04/2019 answer text <p>The following table provides a summary of referrals to Barts Health NHS trust for suspected breast cancer under the national two week wait operational standards, both for urgent general practitioner suspected cancer and for the symptomatic breast two week standard.</p><p> </p><table><tbody><tr><td><p>Symptomatic Breast Referrals</p></td><td><p>2013-14</p></td><td><p>2014-15</p></td><td><p>2015-16</p></td><td><p>2016-17</p></td><td><p>2017-18</p></td><td><p>2018-19 (Year to Date)</p></td></tr><tr><td><p>Barts Health</p></td><td><p>2,920</p></td><td><p>2,763</p></td><td><p>3,318</p></td><td><p>2,736</p></td><td><p>1,706</p></td><td><p>2,247</p></td></tr></tbody></table> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 04/04/2019 11:07:55 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	163 label Biography information for Sir Stephen Timms

1108672

	registered interest
	date	01/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Breast Cancer: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what proportion of women were invited for screening at Central and East London Breast Screening Service within three years of their previous appointment in each month in the last three years.
	tabling member constituency	East Ham
	tabling member printed	Stephen Timms
	uin	239165
	answer	answer is ministerial correction date of answer 04/04/2019 answer text <p>This information is not held centrally in the format requested.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 04/04/2019 11:06:16 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	163 label Biography information for Sir Stephen Timms

1108673

	registered interest
	date	01/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Breast Cancer: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many screening sessions have been delivered by Central and East London Breast Screening Service (a) in Homerton Hospital and (b) at the Sir Ludwig Guttmann Health and Wellbeing Centre in each week in the last year.
	tabling member constituency	East Ham
	tabling member printed	Stephen Timms
	uin	239166
	answer	answer is ministerial correction date of answer 04/04/2019 answer text <p>This information is not held centrally in the format requested.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 239167 question first answered 04/04/2019 11:08:46 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	163 label Biography information for Sir Stephen Timms

1108674

	registered interest
	date	01/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Breast Cancer: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, in which months in the last two years Central and East London Breast Screening Service has met its target of less than 2 per cent of screenings being subject to technical recalls.
	tabling member constituency	East Ham
	tabling member printed	Stephen Timms
	uin	239167
	answer	answer is ministerial correction date of answer 04/04/2019 answer text <p>This information is not held centrally in the format requested.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 239166 question first answered 04/04/2019 11:08:46 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	163 label Biography information for Sir Stephen Timms

1108732

	registered interest
	date	01/04/2019
	answering body	Department for Transport
	answering dept id	27
	answering dept short name	Transport
	answering dept sort name	Transport
	hansard heading	Transport for London: Borrowing
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Transport, whether Transport for London has the power to defer borrowing from one year to the next.
	tabling member constituency	Aberdeen North
	tabling member printed	Kirsty Blackman
	uin	239256
	answer	answer is ministerial correction date of answer 04/04/2019 answer text <p>Transport for London (TfL) may defer its prudential borrowing capacity from one year to the next. TfL is required to give notice to HMG of its intention to defer borrowing before the end of the financial year.</p><p> </p> answering member constituency Hereford and South Herefordshire answering member printed Jesse Norman question first answered 04/04/2019 10:26:57 answering member 3991 label Biography information for Jesse Norman
	tabling member	4357 label Biography information for Kirsty Blackman

1108736

	registered interest
	date	01/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Epilepsy: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will confirm that Serious Medicines Shortage Protocols will not be appropriate for epilepsy treatments and that will be included in published guidance on Serious Medicines Protocols.
	tabling member constituency	Bury South
	tabling member printed	Mr Ivan Lewis
	uin	239183
	answer	answer is ministerial correction date of answer 04/04/2019 answer text <p>A Serious Shortage Protocol is an additional tool to manage and mitigate medication shortages and may be used in the exceptional and rare situation when other measures have been exhausted or are likely to be ineffective.</p><p> </p><p>As the explanatory memorandum of the amending Statutory Instrument acknowledges, Protocols for therapeutic or generic equivalents will not be suitable for all medicines and patients. For example, those types of protocols would not be suitable for treatments for epilepsy or treatments requiring biological products where the medicines that are prescribed need to be prescribed by brand for clinical reasons. In these cases, patients would always be referred back to the prescriber for any decision about their treatment before any therapeutic or generic alternative is supplied.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 04/04/2019 11:09:34 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	441 label Biography information for Mr Ivan Lewis

1108746

	registered interest
	date	01/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Visual Impairment: Surgery
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will make an assessment on the effect of the changes to the NHS tariff for combined cataract and glaucoma surgery on (a) hospital costs and (b) efficiency in the field of ophthalmology.
	tabling member constituency	Dudley North
	tabling member printed	Ian Austin
	uin	239204
	answer	answer is ministerial correction date of answer 04/04/2019 answer text <p>There has been a significant change in clinical practice in ophthalmology since the last tariff prices were set and reference costs used to calculate prices were collected, with a shift to performing Minimally Invasive Glaucoma Surgery (MIGS) instead of open glaucoma procedures which are frequently combined with cataract extraction.</p><p> </p><p>MIGS are significantly cheaper, and both procedures cannot be differentiated using operating procedure code supplement codes. Open/tube glaucoma procedures are nearly always done with a graft of sclera or tutoplast, which triggers multiple procedures so will receive significantly more under the 2019/20 prices than MIGS procedures, which is appropriate.</p><p> </p><p>NHS Improvement has carried out an impact assessment which shows that the national tariff changes should not affect patient access to glaucoma treatment.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 239205 question first answered 04/04/2019 11:12:13 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	1511 label Biography information for Lord Austin of Dudley

1108747

	registered interest
	date	01/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Glaucoma: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will make an assessment of the effectiveness of the changes to the NHS tariff for 2019-2020 in the field of ophthalmology on patient access to glaucoma treatment.
	tabling member constituency	Dudley North
	tabling member printed	Ian Austin
	uin	239205
	answer	answer is ministerial correction date of answer 04/04/2019 answer text <p>There has been a significant change in clinical practice in ophthalmology since the last tariff prices were set and reference costs used to calculate prices were collected, with a shift to performing Minimally Invasive Glaucoma Surgery (MIGS) instead of open glaucoma procedures which are frequently combined with cataract extraction.</p><p> </p><p>MIGS are significantly cheaper, and both procedures cannot be differentiated using operating procedure code supplement codes. Open/tube glaucoma procedures are nearly always done with a graft of sclera or tutoplast, which triggers multiple procedures so will receive significantly more under the 2019/20 prices than MIGS procedures, which is appropriate.</p><p> </p><p>NHS Improvement has carried out an impact assessment which shows that the national tariff changes should not affect patient access to glaucoma treatment.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 239204 question first answered 04/04/2019 11:12:13 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	1511 label Biography information for Lord Austin of Dudley

1108760

	registered interest
	date	01/04/2019
	answering body	Department for Business, Energy and Industrial Strategy
	answering dept id	201
	answering dept short name	Business, Energy and Industrial Strategy
	answering dept sort name	Business, Energy and Industrial Strategy
	hansard heading	Energy: Housing
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, how many individuals gained a Level 5 Diploma in Retrofit Coordination and Risk Management in each of the last five years; and if he will make a statement.
	tabling member constituency	Warwick and Leamington
	tabling member printed	Matt Western
	uin	239304
	answer	answer is ministerial correction date of answer 04/04/2019 answer text <p>The Retrofit Academy and its partners, the Federation of Master Builders, Engie and INCA, developed the Open College Network West Midlands Level 5 Diploma in Retrofit Coordination and Risk Management course.</p><p>The new online Level 5 Diploma in Retrofit Coordination and Risk Management, was developed by the Federation of Master Builders with funding from the Construction Industry Training Board, specifically to support the development of PAS 2035 (Publicly Available Standards for domestic retrofit) in response to the Each Home Counts review.</p><p>The Department does not own the qualification nor hold information on industry uptake.</p> answering member constituency Devizes answering member printed Claire Perry grouped question UIN 239305 239306 question first answered 04/04/2019 09:23:39 answering member 3974 label Biography information for Claire Perry
	tabling member	4617 label Biography information for Matt Western